Cause of death, by non-communicable diseases, ages 5-14 in Myanmar
Myanmar: Cause of death, by non-communicable diseases, ages 5-14 was 25.0% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14 in Myanmar, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14 in Myanmar is 25.0%, measured in 2021.
Compared with earlier readings it is down 18.4% on the previous year and up 7.7% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14 in Myanmar peaked at 30.6% in 2020 and was at its lowest, 20.1%, in 2000.
That places Myanmar 133rd out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14 in Myanmar, year by year
| Year | % of total deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 20.1% | — |
| 2010 | 23.2% | +15.1% |
| 2015 | 26.3% | +13.3% |
| 2019 | 29.8% | +13.3% |
| 2020 | 30.6% | +2.8% |
| 2021 | 25.0% | -18.4% |
Myanmar compared with similar countries
- Myanmar's 25.0% is below the median for lower middle income countries, which is 25.3%, 99% of the median. (47 countries reporting)
- Myanmar's 25.0% is below the median for East Asia & Pacific, which is 33.7%, 74% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 20.1% | 20.1% | 20.1% | 1 |
| 2010s | 26.4% | 23.2% | 29.8% | 3 |
| 2020s | 27.8% | 25.0% | 30.6% | 2 |
Countries ranked near Myanmar
More health data for Myanmar
- Un projection of annual infant deaths, annual growth rate -2.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1576 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,398 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,973 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate -0.759 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0387 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8351 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14 in Myanmar?
- Cause of death, by non-communicable diseases, ages 5-14 in Myanmar was 25.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14 recorded in Myanmar?
- The highest recorded value was 30.6% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14 recorded in Myanmar?
- The lowest recorded value was 20.1% in 2000.
- How does Myanmar rank for cause of death, by non-communicable diseases, ages 5-14?
- Myanmar ranks 133rd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14 rising or falling in Myanmar?
- Over the last ten years it is up 7.7%. The long-run trend across the full record is rising.
- Where does this Myanmar data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.